Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?

PubWeight™: 1.39‹?› | Rank: Top 10%

🔗 View Article (PMID 18205713)

Published in Exp Dermatol on February 01, 2008


K U Schallreuter, P Bahadoran, M Picardo, A Slominski, Y E Elassiuty, E H Kemp, C Giachino, J B Liu, R M Luiten, T Lambe, I C Le Poole, I Dammak, H Onay, M A Zmijewski, M L Dell'Anna, M P Zeegers, R J Cornall, R Paus, J P Ortonne, W Westerhof

Articles citing this

Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol (2012) 2.99

Key role of CRF in the skin stress response system. Endocr Rev (2013) 1.77

Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo. J Invest Dermatol (2015) 1.51

CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci Transl Med (2014) 1.50

Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol (2012) 1.47

Immunohistochemical detection of P53 and Mdm2 in vitiligo. Indian Dermatol Online J (2012) 1.06

Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo. J Invest Dermatol (2014) 1.03

Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells. FASEB J (2013) 1.02

Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff. Exp Dermatol (2009) 0.99

Impaired activation of the Nrf2-ARE signaling pathway undermines H2O2-induced oxidative stress response: a possible mechanism for melanocyte degeneration in vitiligo. J Invest Dermatol (2014) 0.99

Innate immune mechanisms in vitiligo: danger from within. Curr Opin Immunol (2013) 0.97

Vitiligo--part 1. An Bras Dermatol (2014) 0.96

Vitiligo: a possible model of degenerative diseases. PLoS One (2013) 0.94

Heme oxygenase-1 expression protects melanocytes from stress-induced cell death: implications for vitiligo. Exp Dermatol (2011) 0.85

Topical application of bleaching phenols; in-vivo studies and mechanism of action relevant to melanoma treatment. Melanoma Res (2011) 0.81

Immunological Parameters Associated With Vitiligo Treatments: A Literature Review Based on Clinical Studies. Autoimmune Dis (2015) 0.81

Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo. Immunol Rev (2016) 0.80

Vitiligo in adults and children. BMJ Clin Evid (2011) 0.80

Vitiligo and alopecia areata: apples and oranges? Exp Dermatol (2013) 0.79

Oxidative stress and immune system in vitiligo and thyroid diseases. Oxid Med Cell Longev (2015) 0.79

Stimulated human melanocytes express and release interleukin-8, which is inhibited by luteolin: relevance to early vitiligo. Clin Exp Dermatol (2013) 0.78

Interferon-γ induces senescence in normal human melanocytes. PLoS One (2014) 0.77

Evaluation of advanced oxidation protein products, prooxidant-antioxidant balance, and total antioxidant capacity in untreated vitiligo patients. Ann Dermatol (2015) 0.77

Raman Spectroscopy: Incorporating the Chemical Dimension into Dermatological Diagnosis. Indian J Dermatol (2016) 0.75

Correlation of Vitamin D Levels with Pigmentation in Vitiligo Patients Treated with NBUVB Therapy. ISRN Dermatol (2014) 0.75

Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay. PLoS One (2016) 0.75

Dysfunction of Autophagy: A Possible Mechanism Involved in the Pathogenesis of Vitiligo by Breaking the Redox Balance of Melanocytes. Oxid Med Cell Longev (2016) 0.75

Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo. Genes Immun (2015) 0.75

Aspirin induces Nrf2-mediated transcriptional activation of haem oxygenase-1 in protection of human melanocytes from H2 O2 -induced oxidative stress. J Cell Mol Med (2016) 0.75

Vitiligo in adults and children: surgical interventions. BMJ Clin Evid (2015) 0.75

Stability in vitiligo: why such a hullabaloo? J Cutan Aesthet Surg (2009) 0.75

Vitiligo: what's new in the psycho-neuro-endocrine-immune connection and related treatments. Wien Med Wochenschr (2014) 0.75

Articles by these authors

A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol (2001) 6.12

Sonic hedgehog signaling is essential for hair development. Curr Biol (1998) 5.58

Controls of hair follicle cycling. Physiol Rev (2001) 5.49

Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature (1991) 4.27

Chronic anal ulceration due to nicorandil. Br J Dermatol (2004) 3.18

Noggin is a mesenchymally derived stimulator of hair-follicle induction. Nat Cell Biol (1999) 2.99

Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98

Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet (1995) 2.93

Review article: the association of diet with onset and relapse in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2013) 2.82

Localization of GerAA and GerAC germination proteins in the Bacillus subtilis spore. J Bacteriol (2001) 2.36

Splenic T zone development is B cell dependent. J Exp Med (2001) 2.35

Interleukin-15 protects from lethal apoptosis in vivo. Nat Med (1997) 2.22

Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol (1998) 2.20

The genetic analysis of bacterial spore germination. J Appl Bacteriol (1994) 2.19

Selection by two powerful antigens may account for the presence of the major population of human peripheral gamma/delta T cells. J Exp Med (1991) 2.09

Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J (2000) 2.09

Anti-HPV vaccination: a review of recent economic data for Italy. Vaccine (2009) 2.01

Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat Genet (1993) 1.98

Noggin is required for induction of the hair follicle growth phase in postnatal skin. FASEB J (2001) 1.95

Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet (1995) 1.90

Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol (1993) 1.88

Rab27a: A key to melanosome transport in human melanocytes. J Cell Biol (2001) 1.86

Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny. Oncogene (2011) 1.83

Analysis of apoptosis during hair follicle regression (catagen) Am J Pathol (1997) 1.82

Additional microsatellite markers for mouse genome mapping. Mamm Genome (1991) 1.79

Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis (2011) 1.76

Graying: gerontobiology of the hair follicle pigmentary unit. Exp Gerontol (2001) 1.75

The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. Br J Dermatol (2001) 1.75

The development of guidelines for the treatment of vitiligo. Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology. Arch Dermatol (1999) 1.73

Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J (2000) 1.73

Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood (1999) 1.71

Roaccutane treatment guidelines: results of an international survey. Dermatology (1997) 1.70

Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol (2001) 1.68

A multicenter study on the use of pulsed low-intensity direct current for healing chronic stage II and stage III decubitus ulcers. Arch Dermatol (1993) 1.68

Antioxidant activity, lipid peroxidation and skin diseases. What's new. J Eur Acad Dermatol Venereol (2003) 1.67

What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65

From the bench to the bedside: proton pump inhibitors can worsen vitiligo. Br J Dermatol (2007) 1.63

Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5). Nat Genet (1994) 1.63

Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol (1998) 1.62

[Turning white overnight, is it possible?]. Ned Tijdschr Geneeskd (1993) 1.61

Endoluminal ultrasonography of the distal esophagus in systemic sclerosis. Gastroenterology (1993) 1.60

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Retracted Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain. FASEB J (1999) 1.60

Dominant dystrophic epidermolysis bullosa associated with pyloric stenosis and congenital absence of skin. Arch Dermatol (2001) 1.60

Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med (1993) 1.58

Giant oral aphthous ulcers induced by nicorandil. Br J Dermatol (1998) 1.58

Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product. J Cell Biol (1996) 1.57

Anthropometry, carbohydrate and lipid metabolism in the East Flanders Prospective Twin Survey: heritabilities. Diabetologia (2007) 1.56

Melanocytes as "sensory" and regulatory cells in the epidermis. J Theor Biol (1993) 1.55

Ultrasound contrast agents: a review. Ultrasound Med Biol (1994) 1.53

Arthritis, collagenous colitis, and discoid lupus. Ann Intern Med (1994) 1.52

Sonographic guidance for the localization of peripheral pulmonary nodules during thoracoscopy. AJR Am J Roentgenol (1997) 1.52

Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks. Arch Dermatol (2001) 1.51

Occupational hypersensitivity to metal salts, including platinum, in the secondary industry. Allergy (2005) 1.49

Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo. FASEB J (2000) 1.48

Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res (2012) 1.48

PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. J Invest Dermatol (1980) 1.46

Grafting of venous leg ulcers. An intraindividual comparison between cultured skin equivalents and full-thickness skin punch grafts. J Am Acad Dermatol (1991) 1.45

Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophy. J Clin Invest (1996) 1.45

Artifacts in ultrasonic contrast agent studies. J Ultrasound Med (1994) 1.45

Hemodynamic factors affecting uterine artery Doppler waveform pulsatility in sheep. J Ultrasound Med (1998) 1.43

The human hair follicle immune system: cellular composition and immune privilege. Br J Dermatol (2000) 1.42

The genetic analysis of bacterial spore germination. Soc Appl Bacteriol Symp Ser (1994) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

[Extracutaneous manifestations of neutrophilic dermatosis]. Ann Dermatol Venereol (1996) 1.41

EMLA cream as a topical anesthetic for the repeated mechanical debridement of venous leg ulcers: a double-blind, placebo-controlled study. J Am Acad Dermatol (1999) 1.41

Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. J Biol Chem (1998) 1.40

Failure of topical estrogen receptor agonists and antagonists to alter murine hair follicle cycling. J Invest Dermatol (1998) 1.40

Leptin promotes a proinflammatory lipid profile and induces inflammatory pathways in human SZ95 sebocytes. Br J Dermatol (2014) 1.39

Malignant lymphoma and dermatitis herpetiformis. Dermatology (1994) 1.39

[Oral photochemotherapy in vitiligo (author's transl)]. Ann Dermatol Venereol (1979) 1.39

[Effective removal of certain skin pigment spots (lentigines) using the Q-switched ruby laser]. Ned Tijdschr Geneeskd (1997) 1.39

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

[Atypical clinical forms of bullous pemphigoid]. Ann Dermatol Venereol (1990) 1.39

US-assisted bronchoscopy with use of miniature transducer-containing catheters. Radiology (1994) 1.39

Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim Biophys Acta (1996) 1.39

Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest (2000) 1.39

The 'melanocyte-keratin' mystery revisited: neither normal human epidermal nor hair follicle melanocytes express keratin 16 or keratin 6 in situ. Br J Dermatol (2009) 1.39

CRH functions as a growth factor/cytokine in the skin. J Cell Physiol (2006) 1.38

The TGF-beta2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis. Dev Biol (1999) 1.38

Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Oncogene (2011) 1.38

[Practical use of antiseptics in dermatology]. Ann Dermatol Venereol (1989) 1.38

Fibroblastic rheumatism: clinical, histological, immunohistological, ultrastructural and biochemical study of a case. Br J Dermatol (1993) 1.38

The role of the hairless (hr) gene in the regulation of hair follicle catagen transformation. Am J Pathol (1999) 1.38

Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived Neurotrophic functions. Am J Pathol (1999) 1.37

Urticaria from ranitidine. Contact Dermatitis (1983) 1.37

Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol (1998) 1.37

Local longitudinal muscle shortening of the human esophagus from high-frequency ultrasonography. Am J Physiol Gastrointest Liver Physiol (2001) 1.36

Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10. J Biol Chem (2000) 1.36

Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol (1993) 1.35

Transposable B2 SINE elements can provide mobile RNA polymerase II promoters. Nat Genet (2001) 1.35

Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol (1996) 1.35

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Alkaline phosphatase activity and localization during the murine hair cycle. Br J Dermatol (1994) 1.34

Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes. Exp Cell Res (1987) 1.34